Endpoints News· @endpts · X·· 27 天前AI 评分18
AI 导读
在Endpoints纽约AI Day活动上,Ortet CEO Kyunghyun Cho表示,如果没有合适的体系将新药投入使用,AI造出什么其实并不重要。“AI可以工程化分子,但无法工程化药物,”他说。点击收听他在台上其余的“热辣观点”:https://youtu.be/IYW8nWZXvqA?si=HiIWzTyhBImz117Q
正文
It doesn’t really matter what AI makes if there isn’t a proper system to put novel medicines into use, argued Kyunghyun Cho, CEO of Ortet, during Endpoints’ AI Day in New York City. “AI can engineer molecules, but it cannot engineer medicine,” he said. Hear the rest of his on-stage “hot take”: https://youtu.be/IYW8nWZXvqA?si=HiIWzTyhBImz117Q
来源:Endpoints News · x.com